Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    17465468 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation
Conditions: Malignant Neoplasm of Stomach;   Effects of Chemotherapy
Interventions: Drug: Capecitabine/Cisplatin + Sorafenib;   Drug: Capecitabine/Cisplatin

Study has passed its completion date and status has not been verified in more than two years.